Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia.
Disel
Umut
U
Paydas
Semra
S
Yavuz
Sinan
S
Tuncer
Ilhan
I
Alpay
Rana
R
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004431:Ear, External / Q000473:pathology*; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008775:Methylprednisolone / Q000008:administration & dosage; D009503:Neutropenia / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D011994:Recombinant Proteins; D012008:Recurrence; D016463:Sweet Syndrome / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
D000893:Anti-Inflammatory Agents; D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D014740:Vidarabine; D000069585:Filgrastim; D008775:Methylprednisolone; D015255:Idarubicin